☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Telix Pharmaceuticals
Telix Pharmaceuticals Reports the US FDA’s BLA Acceptance with Priority Review of Zircaix (89Zr-DFO-girentuximab) for Kidney Cance...
February 26, 2025
Telix Spins Off Rhine Pharma to Broaden Global Radiopharmaceutical Reach
October 23, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.
